AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Addresses the significant threat of antimicrobial resistance.
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
2d
AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback